APLS
Apellis Pharmaceuticals Inc.
$21.47
+$0.74(+3.57%)
45
Overall
40
Value
45
Tech
50
Quality
Market Cap
$3.80B
Volume
6.49M
52W Range
$16.10 - $35.72
Target Price
$38.06
Key Metrics Overview
| Market Cap | $3.80B | P/E Ratio | N/A |
| 52W High | $35.72 | 52W Low | $16.10 |
| Div Yield | N/A | Payout Ratio | N/A |
| EPS Growth 3Y | 43.4% | 52W Position | 27.4% |
| Overall Score | 45 | Value Score | 40 |
| Quality Score | 50 | Technical Score | 45 |
Growth Analysis
| EPS Current Est | $-0.3 | EPS Next Est | $-1.05 |
| EPS Growth Est | N/A | DPS Growth 3Y | N/A |
Revenue (5Y)
EBITDA (5Y)
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | APLS | $21.47 | +3.6% | 6.49M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Apellis Pharmaceuticals Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW